Medtronic received FDA approval to sell the mySentry Remote Glucose Monitor in the U.S. on January 4, 2012. This remote monitor allows the parents of a child with diabetes to see their child’s continuous glucose monitor (CGM) data during the night from a Paradigm Revel insulin pump while they sleep in another room.
Diabetes technology section
The iBGStar Blood Glucose Monitoring System by AgaMatrix received U.S. Food and Drug Administration (FDA) approval on December 7, 2011. It became available for purchase on May 2, 2012.
Tandem Diabetes Care has raised the bar for what pumpers will expect with their new t:slim insulin pump. Inside a sleek glass, chrome, and glossy black exterior sits a high contrast color screen with an iPhone look designed for ease and speed of use. Behind the screen is a pressure-generated micro-delivery system that allows basal rates to be ajdusted by 0.001 (one thousandths) of a unit per hour. Bolus adjustments can be made in increments as small as 0.01 (one hundredth) of a unit.
One big problem with blood glucose meters has long been that you can’t convert the individual readings into patterns and trends so you can figure out what to do about them. Oh, sure, many meters have software that does this in one fashion or another but downloading the data into software is often difficult because the cable you need is unavailable or lost or left at home or the office. Even a bigger problem occurs when you take the meter to the doctor’s office and they don’t have a cable to use to download data to software for the doctor to analyze and make recommendations.
Dexcom is making more friends. Already having partnerships with Animas and Omnipod, Dexcom has now signed a research and development agreement with Roche Diagnostics U.S. The plan is to integrate Dexcom's continuous glucose monitor into Roche's insulin pumps so you can see trends and blood glucose data in one handheld device.
Here's an excerpt from the announcement:
We've been talking about smart insulin pens for years. A smart pen that includes some of the helpful features found in today's smart pumps would help non-pump patients increase the success of their diabetes management greatly. Pendiq is a new digital insulin pen manufactured by Diamesco Co, that was announced at the European Association for the Study of Diabetes (EASD) meeting in Lisbon in September of 2011.
The SOLO MicroPump Insulin Delivery System is a patch pump originally made by Medingo and purchased by Roche in 2010. Solo received FDA approval in 2009 and is expected to be available in 2012. The system has 4 parts: a micropump composed of reusable electronics plus an insulin reservoir, a remote, and a cradle.